Short-term β-adrenergic regulation of leptin, adiponectin and interleukin-6 secretion in vivo in lean and obese subjects

Diabetes, Obesity and Metabolism

Volumn 10, Issue 11, 2008, Pages 1029-1038

  Goossens, Gijs H ^a   Jocken, J W E ^a   van Baak, M A ^a   Jansen, E H J M ^b   Saris, W H M ^a   Blaak, E E ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Human adipose tissue; Obesity; Secretion; Skeletal muscle; adrenergic stimulation

Indexed keywords

ADIPONECTIN; INTERLEUKIN 6; ISOPRENALINE; LEPTIN;

ABDOMINAL SUBCUTANEOUS FAT; ADRENERGIC SYSTEM; ADULT; ARTICLE; BETA ADRENERGIC STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; IN VIVO STUDY; INSULIN RESISTANCE; LEAN BODY WEIGHT; MALE; OBESITY; SKELETAL MUSCLE;

EID: 54249105845     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2008.00856.x     Document Type: Article

References (49)

1. Trayhurn P, Wood IS. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-355.
2. Rajala MW, Scherer PE. Minireview: The adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003; 144: 3765-3773.
3. Grassi G, Scherer PE, Seravalle G et al. Sympathetic activation in obese normotensive subjects. Hypertension 1995; 25: 560-563.
4. Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994; 89: 2634-2640.
5. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100: 270-278.
6. Rayner DV, Trayhurn P. Regulation of leptin production: Sympathetic nervous system interactions. J Mol Med 2001; 79: 8-20.
7. Baynes KC, Nicholas MD, Shojaee-Moradie F, Umpleby AM, Giannoulis MG. Acute regulation of plasma leptin by isoprenaline in lean and obese fasted subjects. Diabetes Obes Metab 2006; 8: 412-418.
8. Carulli L, Ferrari S, Bertolini M, Tagliafico E, Del Rio G. Regulation of ob gene expression: Evidence for epinephrine-induced suppression in human obesity. J Clin Endocrinol Metab 1999; 84: 3309-3312.
9. Pinkney JH, Coppack SW, Mohamed-Ali V. Effect of isoprenaline on plasma leptin and lipolysis in humans. Clin Endocrinol (Oxf) 1998; 48: 407-411.
10. Ricci MR, Lee MJ, Russell CD et al. Isoproterenol decreases leptin release from rat and human adipose tissue through posttranscriptional mechanisms. Am J Physiol Endocrinol Metab 2005; 288: E798-E804.
11. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749.
12. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 1996; 221: 286-289.
13. Das K, Lin Y, Widen E, Zhang Y, Scherer PE. Chromosomal localization, expression pattern, and promoter analysis of the mouse gene encoding adipocyte-specific secretory protein Acrp30. Biochem Biophys Res Commun 2001; 280: 1120-1129.
14. Yamauchi T, Kamon J, Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946.
15. Ouchi N, Kihara S, Arita Y et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296-1301.
16. Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473-2476.
17. Okamoto Y, Kihara S, Funahashi T, Matsuzawa Y, Libby P. Adiponectin: A key adipocytokine in metabolic syndrome. Clin Sci (Lond) 2006; 110: 267-278.
18. Delporte ML, Funahashi T, Takahashi M, Matsuzawa Y, Brichard SM. Pre- and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion: In vitro and in vivo studies. Biochem J 2002; 367: 677-685.
19. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 2001; 507: 142-146.
20. Puerta M, Abelenda M, Rocha M, Trayhurn P. Effect of acute cold exposure on the expression of the adiponectin, resistin and leptin genes in rat white and brown adipose tissues. Horm Metab Res 2002; 34: 629-634.
21. Yoda M, Nakano Y, Tobe T, Shioda S, Choi-Miura NH, Tomita M. Characterization of mouse GBP28 and its induction by exposure to cold. Int J Obes Relat Metab Disord 2001; 25: 75-83.
22. Imai J, Katagiri H, Yamada T et al. Cold exposure suppresses serum adiponectin levels through sympathetic nerve activation in mice. Obesity (Silver Spring) 2006; 14: 1132-1141.
23. Mohamed-Ali V, Goodrick S, Rawesh A et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
24. Corpeleijn E, Saris WH, Jansen EH, Roekaerts PM, Feskens EJ, Blaak EE. Postprandial interleukin-6 release from skeletal muscle in men with impaired glucose tolerance can be reduced by weight loss. J Clin Endocrinol Metab 2005; 90: 5819-5824.
25. Pedersen BK, Steensberg A, Schjerling P. Muscle-derived interleukin-6: possible biological effects. J Physiol 2001; 536: 329-337.
26. Mohamed-Ali V, Flower L, Sethi J et al. beta-adrenergic regulation of IL-6 release from adipose tissue: In vivo and in vitro studies. J Clin Endocrinol Metab 2001; 86: 5864-5869.
27. Pedersen BK, Steensberg A, Fischer C et al. The metabolic role of IL-6 produced during exercise: Is IL-6 an exercise factor? Proc Nutr Soc 2004; 63: 263-267.
28. Siri WE. The gross composition of the body. Adv Biol Med Phys 1956; 4: 239-280.
29. Abumrad NN, Rabin D, Diamond MP, Lacy WW. Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism 1981; 30: 936-940.
30. Frayn KN, Coppack SW, Humphreys SM, Whyte PL. Metabolic characteristics of human adipose tissue in vivo. Clin Sci (Lond) 1989; 76: 509-516.
31. Blaak EE, Van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA, Saris WH. Beta-adrenergic stimulation of energy expenditure and forearm skeletal muscle metabolism in lean and obese men. Am J Physiol 1994; 267: E306-E315.
32. Goossens GH, Jocken JW, Blaak EE, Schiffers PM, Saris WH, van Baak MA. Endocrine role of the renin-angiotensin system in human adipose tissue and muscle: Effect of beta-adrenergic stimulation. Hypertension 2007; 49: 542-547.
33. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
34. Trayhurn P, Hoggard N, Mercer JG, Rayner DV. Leptin: Fundamental aspects. Int J Obes Relat Metab Disord 1999; 23 (Suppl. 1): 22-28.
35. Klein S, Coppack SW, Mohamed-Ali V, Landt M. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996; 45: 984-987.
36. Barr VA, Malide D, Zarnowski MJ, Taylor SI, Cushman SW. Insulin stimulates both leptin secretion and production by rat white adipose tissue. Endocrinology 1997; 138: 4463-4472.
37. Bornstein SR, Abu-Asab M, Glasow A et al. Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes 2000; 49: 532-538.
38. Gettys TW, Harkness PJ, Watson PM. The beta 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology 1996; 137: 4054-4057.
39. Esler M, Vaz M, Collier G et al. Leptin in human plasma is derived in part from the brain, and cleared by the kidneys. Lancet 1998; 351: 879.
40. Taira N, Yabuuchi Y, Yamashita S. Profile of beta-adrenoceptors in femoral, superior mesenteric and renal vascular beds of dogs. Br J Pharmacol 1977; 59: 577-583.
41. Eikelis N, Lambert G, Wiesner G et al. Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function. Am J Physiol Endocrinol Metab 2004; 286: E744-E752.
42. Tan GD, Debard C, Funahashi T et al. Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy. Diabetologia 2005; 48: 1585-1589.
43. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities -the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374-381.
44. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935.
45. Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
46. Carey AL, Bruce CR, Sacchetti M et al. Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia 2004; 47: 1029-1037.
47. Bastard JP, Jardel C, Bruckert E et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85: 3338-3342.
48. Lyngso D, Simonsen L, Bulow J. Interleukin-6 production in human subcutaneous abdominal adipose tissue: The effect of exercise. J Physiol 2002; 543: 373-378.
49. Hiscock N, Chan MH, Bisucci T, Darby IA, Febbraio MA. Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: Evidence of fiber type specificity. FASEB J 2004; 18: 992-994.